Michael A. Evans, BS, RPh, describes why patient follow-up is necessary during transitions of care scenarios following the initiation of treatment with an anticoagulant. Warfarin therapy requires close, regular monitoring by a patient’s healthcare team; thus, the management of patients taking warfarin can be a challenge, especially during transitions of care, notes Mr Evans. In contrast, he adds, the management of patients taking direct-acting oral anticoagulants is comparatively easier, as these agents do not require routine monitoring.
Regardless of which treatment option is prescribed for a patient, patient follow-up is important during transitions of care scenarios because it can help prevent drug-related adverse events and thromboembolic complications, says Mr Evans. Patients and their caregivers need to be educated about the purpose of their treatment, the potential for side effects and drug-drug interactions, and the importance of taking their treatment as prescribed. The nature and frequency of follow-up care should be individualized following an assessment by a clinician, he suggests.
Institutions should establish protocols for appropriate follow-up care, which includes follow-up phone calls. The individual that makes the follow-up phone calls with the patient following a transition of care need not be the physician. Rather, any member of a patient’s multidisciplinary care team (eg, a nurse, pharmacist, assistant) can make follow-up phone calls.
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More